IATDMCT 2017

Presentation information

Print

Oral

[O25-2] O25-2: CNS and miscellaneous

Mon. Sep 25, 2017 1:30 PM - 2:30 PM Room D (1F)

Chairs: Koichiro Tsuchiya, Japan / Yasuo Takeda, Japan

[O25-2-1] CYP2C19 polymorphism affects the efficacy but not drowsiness in the low dose clobazam therapy

Sachiyo Hashi1, Ikuko Yano2, Mai Shibata3, Riki Matsumoto4, Akio Ikeda5, Atsushi Yonezawa6, Ryosuke Takahashi7, Kazuo Matsubara8 (1.Kyoto University Hospital, 2.Kobe University Hospital, 3.Kyoto University, 4.Kyoto University, 5.Kyoto University, 6.Kyoto University, 7.Kyoto University, 8.Kyoto University Hospital)

Keywords:CYP2C19, clobazam, N-desmethylclobazam, drowsiness, side effect

Abstract password authentication.
Password to view abstracts and 'Participants' page is announced on the e-blast sent to early-bird/advanced registrants on September 13. It is also on the page 7 of IATDMCT 2017 PROGRAM BOOK.

Password